4//SEC Filing
Calabrese Salvatore 4
Accession 0001209191-23-021260
CIK 0001819411other
Filed
Mar 26, 8:00 PM ET
Accepted
Mar 27, 5:28 PM ET
Size
8.1 KB
Accession
0001209191-23-021260
Insider Transaction Report
Form 4
Calabrese Salvatore
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2023-03-23+50,000→ 50,000 totalExercise: $4.84Exp: 2033-03-23→ Common Stock (50,000 underlying) - Award
Restricted Stock Units
2023-03-23+25,000→ 25,000 total→ Common Stock (25,000 underlying)
Footnotes (3)
- [F1]The shares underlying the option shall vest 25% on March 23, 2024 and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
- [F3]The RSUs shall vest 25% on March 23, 2024 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.
Documents
Issuer
Gain Therapeutics, Inc.
CIK 0001819411
Entity typeother
Related Parties
1- filerCIK 0001851958
Filing Metadata
- Form type
- 4
- Filed
- Mar 26, 8:00 PM ET
- Accepted
- Mar 27, 5:28 PM ET
- Size
- 8.1 KB